Rapport
Measles & Rubella Partnership Operational Strategy 2026–2030
The Measles & Rubella Partnership (M&RP) enters the second half of the decade at a critical juncture: the Midterm Review of the Measles & Rubella Strategic Framework 2021–2030 (MRSF), highlights that despite progress between 2021–2024, the world remains off track to achieve measles and rubella elimination by 2030. Persistent immunity gaps, increasing frequency and scale of outbreaks, inequities in access, and a tightening global health financing environment continue to constrain progress.
In response, the M&RP Operational Strategy 2026–2030 (Operational Strategy) has been developed to serva as a focused operational plan for the remainder of the decade, translating recommendations and coursecorrections identified through the Midterm Review of the MRSF into actionable approaches for the M&RP to take forward.
Auteurs
Langues
- Anglais
Année de publication
2026
Type
Rapport
Catégories
- Initiatives mondiales
Maladies
- Rougeole
- Rubéole
Organisations
- La Foundation Bill et Melinda Gates
- Gavi, l'Alliance du vaccin
- UNICEF
- Centres de prévention et de contrôle des maladies (CDC)
- Organisation Mondiale de la Santé (OMS)
Mots-clés
- IA2030
